Search research articles
Contact Us
Filters
Showing results (291-300 of 296) with videos related to
Page
of 30
Sort By:
You have reached the last page of results.
This site can display upto 296 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2024
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy
Joel Neal, Nick Pavlakis, Sang-We Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 24, 2025
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study
Solange Peters, Christian Schulz, Martin Reck, et al.
Lancet (London, England)
|
June 5, 2025
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
Luis Paz-Ares, Hossein Borghaei, Stephen V Liu, et al.
Water Research
|
January 8, 2021
Expanding ecological assessment by integrating microorganisms into routine freshwater biomonitoring
M Sagova-Mareckova, J Boenigk, A Bouchez, et al.
Biochemistry
|
June 27, 2015
Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites
Christopher T Veldkamp, Eva Kiermaier, Skylar J Gabel-Eissens, et al.
ESC Heart Failure
|
February 19, 2026
One-Year Follow-up of Patients with Severe tricuspid Regurgitation. Prognostic Impact of Right Heart Failure Staging
Juan Carlos Gómez Polo, Itziar Gómez-Salvador, Patricia Mahía Casado, et al.
Page
of 30
Search research articles
Search
Showing results (291-300 of 296) with videos related to
Sort By:
Page
of 30
You have reached the last page of results.
This site can display upto 296 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2024
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy
Joel Neal, Nick Pavlakis, Sang-We Kim, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 24, 2025
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study
Solange Peters, Christian Schulz, Martin Reck, et al.
Lancet (London, England)
|
June 5, 2025
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
Luis Paz-Ares, Hossein Borghaei, Stephen V Liu, et al.
Water Research
|
January 8, 2021
Expanding ecological assessment by integrating microorganisms into routine freshwater biomonitoring
M Sagova-Mareckova, J Boenigk, A Bouchez, et al.
Biochemistry
|
June 27, 2015
Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites
Christopher T Veldkamp, Eva Kiermaier, Skylar J Gabel-Eissens, et al.
ESC Heart Failure
|
February 19, 2026
One-Year Follow-up of Patients with Severe tricuspid Regurgitation. Prognostic Impact of Right Heart Failure Staging
Juan Carlos Gómez Polo, Itziar Gómez-Salvador, Patricia Mahía Casado, et al.
Page
of 30